COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 282: Articles 2811-2820  | Next

Mutability and hypermutation antagonize immunoglobulin codon optimality
McGrath, J. J., Park, J., Troxell, C. A., Chervin, J. C., Li, L., Kent, J. R., Changrob, S., Fu, Y., Huang, M., Zheng, N.-Y., Wilbanks, G. D., Nelson, S. A., Sun, J., Inghirami, G., Madariaga, M. L. L., Georgiou, G., Wilson, P. C.
10.1101/2024.03.13.584690 — Posted: 2024-03-14
The association between prolonged SARS-CoV-2 symptoms and work outcomes
Venkatesh, A., Yu, H., Malicki, C., Gottlieb, M., Elmore, J. G., Hill, M. J., Idris, A. H., Montoy, J. C. C., O'Laughlin, K. N., Rising, K. L., Stephens, K. A., Spatz, E. S., Weinstein, R. A., the INSPIRE Group
10.1101/2024.03.10.24304054 — Posted: 2024-03-13
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variant JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study
de Prost, N., Audureau, E., Guillon, A., Handala, L., Preau, S., Guigon, A., Uhel, F., Le Hingrat, Q., Delamaire, F., Grolhier, C., Tamion, F., Moisan, A., Darreau, C., Thomin, J., Contou, D., Henry, A., Daix, T., Hantz, S., Saccheri, C., Giordanengo, V., Pham, T., Chaghouri, A., Bay, P., Pawlotsky, J., Fourati, S.
10.1101/2024.03.11.24304075 — Posted: 2024-03-13
Sex differences in symptoms following the administration of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years of age in Germany (CoVacU5): a retrospective cohort study
Moor, J., Toepfner, N., von Meissner, W. C. G., Berner, R., Moor, M. B., Kublickiene, K., Strumann, C., Chao, C.-M.
10.1101/2024.03.08.24303999 — Posted: 2024-03-13
Preoperative COVID-19 Vaccination is Associated with Decreased Perioperative Mortality after Major Vascular Surgery
Ratner, M., Garg, K., Chang, H., Nigalaye, A., Medvedovsky, S., Jacobowitz, G., Siracuse, J. J., Patel, V. I., Schermerhorn, M. L., DiMaggio, C., Rockman, C.
10.1101/2024.03.11.24304133 — Posted: 2024-03-13
SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug discovery
Kremling, V., Falke, S., Fernandez-Garcia, Y., Ehrt, C., Kiene, A., Klopprogge, B., Scheer, T. E. S., Barthels, F., Middendorf, P., Kuehn, S., Guenther, S., Rarey, M., Chapman, H. N., Oberthuer, D., Sprenger, J.
10.1101/2024.03.13.583470 — Posted: 2024-03-13
Changes in the senescence profile and immune checkpoints in HIV-infected individuals after COVID-19
Crespo-Bermejo, C., Brochado-Kith, O., Grande-Garcia, S., Lara-Aguilar, V., Llamas-Adan, M., Arca-Lafuente, S., Martin-Carbonero, L., de los Santos, I., Jimenez Sousa, M. A., Resino, S., Berenguer, J., Madrid, R., Fernandez-Rodriguez, A., Briz, V.
10.1101/2024.03.12.584682 — Posted: 2024-03-13
Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
Carolin, A., Bishop, C. R., Yan, K., Nguyen, W., Tang, B., Rawle, D. J., Suhrbier, A.
10.1101/2024.03.12.584739 — Posted: 2024-03-13
Experiences of physiotherapists working with adults living with Long COVID in Canada: a qualitative study
Kim, C., Lin, C., Wong, M., Al Hamour Al Jarad, S., Gao, A., Kaufman, N., McDuff, K., Brown, D. A., Cobbing, S., Minor, A., Chan Carusone, S., O'Brien, K. K.
10.1101/2024.03.10.24304061 — Posted: 2024-03-12
Mutational Profiling of SARS-CoV-2 PLpro in human cells reveals requirements for function, structure, and drug escape
Wu, X., Go, M., Nguyen, J. V., Kuchel, N. W., Lu, B. G. C., Lowes, K. N., Calleja, D. J., Mitchell, J. P., Lessene, G., Komander, D., Call, M. E., Call, M. J.
10.1101/2024.03.11.584210 — Posted: 2024-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).